In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections ; volume:14 ; number:1 ; day:7 ; month:6 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (7.6.2024), 1-10, 12.2024
- Urheber
-
Ajmal, Amar
Shahab, Muhammad
Waqas, Muhammad
Zheng, Guojun
Zulfat, Maryam
Bin Jardan, Yousef A.
Wondmie, Gezahign Fentahun
Bourhia, Mohammed
Ali, Ijaz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-63064-1
- URN
-
urn:nbn:de:101:1-2408151258111.475066231053
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ajmal, Amar
- Shahab, Muhammad
- Waqas, Muhammad
- Zheng, Guojun
- Zulfat, Maryam
- Bin Jardan, Yousef A.
- Wondmie, Gezahign Fentahun
- Bourhia, Mohammed
- Ali, Ijaz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dengue virus
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Dengue-Virus-Infektionen : eine szientometrische Analyse
Human antibody response to dengue virus: implications for dengue vaccine design
The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus
Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus
Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns
In silico design and evaluation of multi-epitope dengue virus vaccines: a promising approach to combat global dengue burden
Dengue encephalopathy in an adult due to dengue virus type 1 infection
Testung antiviraler Substanzen gegen das Dengue-Virus
Entwicklung von Hemmstoffen der Dengue-Virus-Protease
Identifizierung neuer Dengue Virus Typ-2 Proteaseinhibitoren
Dengue virus
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Dengue-Virus-Infektionen : eine szientometrische Analyse
Human antibody response to dengue virus: implications for dengue vaccine design
The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus
Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus
Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns
In silico design and evaluation of multi-epitope dengue virus vaccines: a promising approach to combat global dengue burden
Dengue encephalopathy in an adult due to dengue virus type 1 infection
Testung antiviraler Substanzen gegen das Dengue-Virus
Entwicklung von Hemmstoffen der Dengue-Virus-Protease
Identifizierung neuer Dengue Virus Typ-2 Proteaseinhibitoren
Dengue virus
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Dengue-Virus-Infektionen : eine szientometrische Analyse
Human antibody response to dengue virus: implications for dengue vaccine design
The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus
Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus
Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns
In silico design and evaluation of multi-epitope dengue virus vaccines: a promising approach to combat global dengue burden
Dengue encephalopathy in an adult due to dengue virus type 1 infection
Testung antiviraler Substanzen gegen das Dengue-Virus
Entwicklung von Hemmstoffen der Dengue-Virus-Protease